Hims & Hers to launch a generic for Novo’s older GLP-1
Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version of Novo ...
Becker's Hospital Review7h
Hims & Hers to sell generic weight loss drug in 2025
Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.
kffhealthnews10h
Lawsuits Say GoodRx, PBMs Quash Reimbursements To Small Pharmacies
CVS Caremark and Express Scripts, along with GoodRx and others, are accused of working together to suppress reimbursements to independent pharmacies in at least three class-action lawsuits. Also, Hims ...
Benzinga.com6d
Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why
Hims & Hers shares had previously surged after announcing they would sell compounded versions of GLP-1 injections. What Happened: A report from the FDA on Wednesday shows that all doses of Novo ...
Seeking Alpha19d
HIMS: GLP-1 Is Just The Beginning
Hims & Hers is revolutionizing healthcare with affordable, convenient telehealth services, leading to a 260% stock increase in the last year. The company benefits from GLP-1 drug sales and is ...
Morningstar1d
Hims & Hers Health Inc Ordinary Shares - Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Benzinga.com29d
Hims & Hers Health Stock Is Rising Monday: What's Going On?
Hims & Hers Health will join the S&P SmallCap 600 prior to the opening of trading on Wednesday. Hims & Hers will replace Vector Group, which is being acquired by JT Group. Hims & Hers Health Inc ...
Hims & Hers Health plans to offer generic version of Novo Nordisk's diabetes drug in 2025
Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.